The synthesis of new ester derivatives of betulin (3a-c) and betulinic acid (4) with conjugated linoleic acid isomers (CLA; in a mixture of 43.4% 9c, 11t; 49.5% 10t, 12c; 7.1% other isomers) is presented. Esterification was carried out with N,N'-dicyclohexylcarbodiimide (DCC) as the coupling agent in the presence of 4-dimethylamino-pyridine (DMAP) in dichloromethane (or pyridine). The in vitro cytotoxic effect of betulin (1), betulinic acid (2), a mixture of CLA isomers and their derivatives (3a-c, 4) was examined using the MTT assay against four cancer cell lines (P388, CEM/C2, CCRF/CEM and HL-60) and the SRB assay on the HT-29 cell line. Ester 4 was the most active among the esters synthesized against the CEM/C2 cell line with an ID 50 value 16.9  6.5 μg/mL. Betulin (1), betulinic acid (2) and CLA were the most active agents against the cancer cell lines studied.
Our interest in betulin (1) and betulinic acid (2) is connected with their numerous biological activities, especially anticancer activity. Betulin (1) has shown antiallergic, anti-inflammatory [1] , antimicrobial [2] , antiviral [3] and cytotoxic activity against cancer cell lines [4] [5] [6] [7] . Unfortunately, it is also cytotoxic to normal cell lines [8] . Betulinic acid (2) is non-toxic to normal cells [9] and exhibits a broad spectrum of interesting and valuable activities. First of all, betulinic acid exhibits anticancer [10] [11] [12] activity and induces the process of apoptosis [13] in various human cancer cell lines. Betulinic acid and its esters show antiviral (anti-HIV-1 [14, 15] and anti-HSV [16] ), antimalarial [17] , anti-inflammatory [18] , hepatoprotective [19] , antibacterial and antifungal [20] properties. Betulinic acid inhibits some enzymes, e.g. phospholipase A 2 [21] , aminopeptidase N [22] , topoisomerase type I [23] and cAMPdependent protein kinase [24] .
The conjugated linoleic acids (CLA) are another group of natural compounds in which we are interested. CLA are found in the milk of ruminants and in bovine meat [25] . Two isomers of CLA, 9 cis, 11 trans and 10 trans, 12 cis, are known for their biological activities. Today, CLA have found an application as dietary supplements in the management of body weight. CLA also inhibit the growth of cancer cells [26] and show antioxidant and antiatherogenic properties [27] . These compounds display a positive effect on the immune system [28] , reduce fat deposition and increase lipolysis in adipocytes [29] .
The idea of synthesis of ester derivatives of betulin and betulinic acid with isomers of CLA was partially inspired by recent studies in which esters of betulin with amino acids showed higher cytotoxic activity than free betulin [30] . Esters of betulin with diacyl phosphatidic acid have been recently synthesized [31] . In this work, the synthesis of new ester derivatives of betulin (3a-c) and betulinic acid (4) with conjugated linoleic acid (in a mixture of 43.4% 9c, 11t; 49.5% 10t, 12c; 7.1% other isomers) is presented. We expected that the ester derivatives containing both bioactive molecules (betulin or betulinic acid and CLA) would also possess valuable antiproliferative activity, which could find an application as prodrugs in anticancer therapy. The preliminary results of these studies were presented partially at the 59 th International Congress of the GA [32] . The esters of betulin with CLA 3a and 3b were obtained in good yields (78% and 69%, respectively) ( Figure 1 ). They were prepared in a one-step synthesis according to a procedure published previously [31] with the application of N,N'dicyclohexylcarbodiimide (DCC) as the coupling agent in the presence of 4-dimethylamino-pyridine (DMAP) in dichloromethane. Preparation of the betulin monoester (3b) required low temperature (ice bath) to obtain selective esterification of the hydroxy group at C-28. Synthesis of betulin monoester (3c) required the protection of the hydroxy group at C-28 with an acetyl group and its deprotection after esterification of the hydroxy group at C-3. Therefore, ester 3c was obtained in three steps with a final yield of 36%. The CLA ester of betulinic acid (4, Scheme 2) was achieved in 66% yield without any protection of the carboxylic group. Esterification was carried out under the same reaction conditions (DCC, DMAP) as for esters 3a and 3b, but pyridine was used as the solvent (Figure 2 ).
The final products were purified by column chromatography on silica gel. They were obtained as inseparable mixtures of isomeric (9c, 11t and 10t, 12c) acid esters in the form of a colourless oil. The structures of all products were confirmed by their spectral data ( 1 H NMR, 13 The presence of signals at 78.9 and 62.5 ppm and also at 173.7 and 174.3 ppm in the 13 C NMR spectrum of 3a confirmed the presence of two ester groups. The four multiplets at 5.29, 5.64, 5.93 and 6.28 ppm in the 1 H NMR spectrum, according to our earlier assignation [33] , were the signals of four olefinic protons of the conjugated double bond system of CLAs (H-9',13"; H-12',10"; H-10',12" and H-11',11", respectively). The signals of carbon atoms forming these double bonds were present in the 13 C NMR spectrum at 134.82 (C-12'), 134.61 (C-10"), 130.18 (C-13"), 129.92 (C-9'), 128.72 (C-10'), 128.58 (C-12"), 125.67 (C-11") and 125.56 (C-11') ppm.
The absorption bands at 1732 cm -1 and 3498 cm -1 in the IR spectrum of 3b confirmed the presence of carboester and hydroxy groups in this product. The multiplets of the CH 2 -28 protons were situated in the 1 H NMR spectrum at 3.83 and 4.25 ppm, whereas a doublet of doublets of H-3 was observed in the same region ( = 3.17) as in the spectrum of betulin. The values of the chemical shifts of these protons proved the esterification of the hydroxy group at C-28 only.
Two absorption bands at 1728 and 3470 cm -1 in the IR spectrum of 3c also indicated that only one hydroxy group was esterified. The position ( 4.46) of the doublet of doublets (J = 10.8 and 5.4 Hz) indicated that the hydroxy group at C-3 was esterified. The protons of the CH 2 -28 group gave two doublets at 3.33 and 3.79 ppm, as in the spectrum of betulin.
The structure of the betulinic acid ester with CLA (4) was also confirmed by spectral data. In the IR spectrum of product 4, the absorption bands at 1729 and 1693 cm -1 indicated carboester and carboxy groups, respectively. Esterification of the secondary hydroxy group in betulinic acid was confirmed by the signal of H-3 at 4.47 ppm. In the 1 H NMR spectrum, the broad signal of a carboxylic proton at 10.26 ppm was also observed. The presence of the CLA part in the esters 3b, 3c and 4 was confirmed by the signals of olefinic protons in the 1 H NMR spectra and signals of carbon atoms of the dienoic system in the 13 C NMR spectra.
The biological tests for cytotoxic activity were carried out at the Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, Wrocław, Poland. The in vitro cytotoxic effect of betulin (1), betulinic acid (2) and the mixture of CLA and esters (3a-c, 4) was examined using the SRB (sulforhodamine B) [34] assay for adherent cells and the MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide) [35] cytotoxicity assay for non-adherent cells. Five different cell lines were used: P388 (mouse leukemia), CCRF/CEM (human T cell lymphoblast-like cell line), CEM/C2 (camptothecin-resistant derivative of the CCRF/CEM cell line), HL-60 (human promyelocytic leukemia) and HT-29 (human colon cancer). All compounds were dissolved in 10% DMSO to a concentration of 1 mg/mL and subsequently diluted in culture medium to reach the required concentrations. DMSO, which was used as a solvent, did not exert any inhibitory effect on cell proliferation. The results of the biological tests are presented in Table 1 . The preliminary tests indicated that betulin (1), betulinic acid (2) and CLA were the most active agents against the cancer cell lines studied. The ester products (3a-c, 4) showed weaker antiproliferative activity in comparison with betulin (1), betulinic acid (2) and CLA. Betulinic acid (2) was the most potent compound against three cell lines (P388, CEM/C2 and HL-60), and its IC 50 value was the lowest for the HL-60 cell line (0.5 ± 0.3 μg/mL). Betulin (1) was the most active against the CEM/C2 cell line, and the IC 50 value was 1.8  1.9 μg/mL. The cytotoxic activity of betulin (1) was also the highest against the CCRF/CEM and HT-29 cell lines (4.3 ± 2.1 μg/mL and 6.8  1.6 μg/mL, respectively). The antiproliferative effect of betulin was stronger than the effect of betulinic acid on the same cell lines. The mixture of CLA was more potent than the ester products against all lines, and its IC 50 value was the lowest for the CEM/C2 cell line (4.3  2.9 μg/mL). Ester 4 was the most active among the synthesized esters against the CEM/C2 cell line with an IC 50 value of 16.9  6.5 μg/mL, but its activity was four times weaker than the mixture of CLA on the same cell line. These results suggest that the free carboxylic group is important for the antiproliferative effect of CLA. The betulin diester with conjugated linoleic acid (3a), characterized by the lowest polarity among all the tested compounds, was more cytotoxic than the monoesters of betulin (3b, 3c) against all cell lines tested except HT-29.
Experimental
Substrates: Betulin (1) was isolated from white birch bark by extraction according to a described procedure [31] . Betulinic acid (2) was obtained by oxidation of betulin with Jones reagent to betulonic acid and reduced with NaBH 4 , according to the procedure described by Kim et al. [36] . The IR and NMR data for betulin and betulinic acid were in accordance with literature reports [37] . The physical data were compared with betulin and betulinic acid standards (Sigma-Aldrich). CLA were obtained by alkaline isomerisation of linoleic acid [33] . Cell culture: Cancer cell lines were obtained from ATCC (Rockville, Maryland, USA). All the cell lines were maintained at the Institute of Immunology and Experimental Therapy, Wroclaw, Poland. Cancer cell lines P388 (mouse leukemia), CCRF/CEM (human T cell lymphoblast-like cell line), HL-60 (human promyelocytic leukemia) and CEM/C2 (camptothecin-resistant derivative of the CCRF/CEM cell line) were cultured in RPMI 1640 medium (Gibco, Scotland, UK) with 2 mM L-glutamine, 4.5 g/L glucose, 1.0 mM sodium pyruvate and 10% fetal bovine serum (all from Sigma-Aldrich Chemie GmbH, Steinheim, Germany). The cell line HT-29 (human colon cancer) was cultured in RPMI 1640+Opti-MEM (1:1) (both from Gibco, Scotland, UK) supplemented with 2 mM L-glutamine, 1.0 mM sodium pyruvate and 5% fetal bovine serum (Sigma-Aldrich Chemie GmbH, Steinheim, Germany). All culture media were supplemented with 100 units/mL penicillin and 100 µg/mL streptomycin (both from Polfa Tarchomin S.A., Warsaw, Poland). All cell lines were grown at 37°C in a 5% CO 2 humidified atmosphere. The compounds (betulin 1, betulinic acid 2, 3a-c, 4, CLA) were dissolved in DMSO and culture medium (1:9) to a concentration of 1 mg/mL, and subsequently diluted in the culture medium to reach the required concentrations (0.1, 1, 10 and 100 μg/mL). Twenty-four h before addition of the tested compounds, the cells were plated in 96-well plates (Sarstedt, Germany) at a density of 1x10 4 cells per well. Assays were performed with 72 h of exposure to varying concentrations of the tested agents.
Synthesis of ester (3c):

Statistical evaluation:
One-way analysis of variance (ANOVA) followed by a Mann-Whitney U Test was applied. P-values <0.05 were considered significant.
